Get 20% Off Journals at LWW.com

Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA).

Dalton Trans 2014 Apr;43(13):4950-61

Department of Chemistry and Chemical Biology, McMaster University, 1280 Main St. West, Hamilton, Ont., CanadaL8S 4M1.

A series of C-hydroxy carborane derivatives of (S)-2-(3-((S)-5-amino-1-carboxypentyl)ureido)-pentanedioic acid were prepared as a new class of boron rich inhibitors of prostate specific membrane antigen (PSMA), which is overexpressed on prostate cancer tumours and metastases. Closo-, nido- and iodo-carborane conjugates were prepared and screened in vitro where the water soluble iodinated cluster had the highest affinity with an IC50 value (73.2 nM) that was comparable to a known PSMA inhibitor 2-(phosphonomethyl)-pentanedioic acid (PMPA, 63.9 nM). The radiolabeled analogue was prepared using (123)I and the biodistribution determined in a prostate cancer model derived from a PSMA positive cell line (LNCaP) at 1, 2, 4, 6 and 24 h post injection (n = 4 per time point). The results showed good initial tumour uptake of 4.17% at 1 h, which remained at that level only decreasing somewhat at 6 h (3.59%). At the latter time point tumour-to-blood and tumour-to-muscle ratios peaked at 3.47 at 25.52 respectively. There was significant off-target binding particularly in the liver and gall bladder and a surprising amount of deiodination in vivo. Notwithstanding, this work demonstrates that carboranes can be used to prepare potent ligands for PSMA creating the opportunity to develop a new class of BNCT agents for prostate cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3dt53189aDOI Listing
April 2014
Get 20% Off Journals at LWW.com

Similar Publications

Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.

Urol Int 2021 Feb 25:1-10. Epub 2021 Feb 25.

Department of Urology, Rostock University, Rostock, Germany.

Background: Observational studies generate information on real-world therapy and complement data from prospective randomized trials. LEAN is an open-label, non-interventional, multi-centre, German cohort study on leuprorelin in routine clinical practice.

Objectives: To extend knowledge on the use, effectiveness, and tolerability of HEXAL/Sandoz leuprorelin (in this article, the term Leuprone® HEXAL® covers Leuprorelin Sandoz® as well) solid implant in patients with prostate cancer (PCa) in a real-world setting. Read More

View Article and Full-Text PDF
February 2021

IPEM Topical Report: An international IPEM survey of MRI use for external beam radiotherapy treatment planning.

Phys Med Biol 2021 Feb 25. Epub 2021 Feb 25.

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.

Introduction/background: Despite growing interest in Magnetic Resonance Imaging (MRI), integration in external beam radiotherapy (EBRT) treatment planning uptake varies globally. In order to understand the current international landscape of MRI in EBRT a survey has been performed in 11 countries. This work reports on differences and common themes identified. Read More

View Article and Full-Text PDF
February 2021

Relationship between nuclear DNA fragmentation, mitochondrial DNA damage and standard sperm parameters in spermatozoa of infertile patients with leukocytospermia.

J Gynecol Obstet Hum Reprod 2021 Feb 22:102101. Epub 2021 Feb 22.

Laboratory of Human Molecular Genetics, Faculty of Medicine, Avenue Majida Boulila, 3029, Sfax, Tunisia.

The association of leukocytospermia with male fertility is still under debate. Our objective is to evaluate the impact of leukocytospermia on nuclear and mitochondrial DNA (mtDNA), on semen parameters as well as on biomarkers, which include oxidative stress and inflammatory cytokines, in Tunisian infertile men. The studied patients were divided into two groups: patients without leukocytospermia (Group 1) and patients with leukocytospermia (Group 2). Read More

View Article and Full-Text PDF
February 2021

Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.

PLoS One 2021 25;16(2):e0247827. Epub 2021 Feb 25.

Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Background: The aim of this study was to identify novel genes in promoting primary prostate cancer (PCa) progression and to explore its role in the prognosis of prostate cancer.

Methods: Four microarray datasets containing primary prostate cancer samples and benign prostate samples were downloaded from Gene Expression Omnibus (GEO), then differentially expressed genes (DEGs) were identified by R software (version 3.6. Read More

View Article and Full-Text PDF
February 2021